OSMT Projected Dividend Yield
Osmotica Pharmaceuticals plc ( NASDAQ : OSMT )Osmotica Pharmaceuticals is a holding company. Through its subsidiaries, Co. is focused on the development and commercialization of products that target markets with underserved patient populations. Co.'s promoted products include: M-72, which is for the treatment of attention deficit hyperactivity disorder (ADHD) in patients aged 13 to 65; Arbaclofen ER, which is for the treatment of multiple sclerosis spasticity; and OS870, which is for the treatment of neurodegenerative disorder. Co.'s non-promoted products include Methylphenidate ER, which is for the treatment of ADHD and Venlafaxine ER tablets, which is for the treatment of depressive disorder and social anxiety disorder. 21 YEAR PERFORMANCE RESULTS |
OSMT Dividend History Detail OSMT Dividend News OSMT Competitors News |
Year |
Declaration Date |
Ex-Dividend Date |
Record Date |
Payable Date |
Dividend $ Amount |
Total: |
0.0000 |